The role of endoplasmic reticulum stress in hippocampal insulin resistance

Experimental Neurology
Catrina Sims-RobinsonEva L Feldman

Abstract

Metabolic syndrome, which includes hypertension, hyperglycemia, obesity, insulin resistance, and dyslipidemia, has a negative impact on cognitive health. Endoplasmic reticulum (ER) stress is activated during metabolic syndrome, however it is not known which factor associated with metabolic syndrome contributes to this stress. ER stress has been reported to play a role in the development of insulin resistance in peripheral tissues. The role of ER stress in the development of insulin resistance in hippocampal neurons is not known. In the current study, we investigated ER stress in the hippocampus of 3 different mouse models of metabolic syndrome: the C57BL6 mouse on a high fat (HF) diet; apolipoprotein E, leptin, and apolipoprotein B-48 deficient (ApoE 3KO) mice; and the low density lipoprotein receptor, leptin, and apolipoprotein B-48 deficient (LDLR 3KO) mice. We demonstrate that ER stress is activated in the hippocampus of HF mice, and for the first time, in ApoE 3KO mice, but not LDLR 3KO mice. The HF and ApoE 3KO mice are hyperglycemic; however, the LDLR 3KO mice have normal glycemia. This suggests that hyperglycemia may play a role in the activation of ER stress in the hippocampus. Similarly, we also demonstrate that impair...Continue Reading

References

Jan 1, 1993·Brain Research Bulletin·D P FiglewiczI Ocrant
Jan 29, 1993·Brain Research·D P FiglewiczD M Dorsa
Apr 3, 1999·The Journal of Biological Chemistry·L Y QiaoX J Sun
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·V A SkeberdisM V Bennett
Sep 26, 2001·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·M Tschöp, M L Heiman
Oct 1, 2003·Clinical and Experimental Pharmacology & Physiology·T D WilliamsJ M Overton
Dec 6, 2003·Science·Morris F White
Oct 2, 2004·Nature Medicine·Mary-Elizabeth Patti, Barbara B Kahn
Oct 16, 2004·Science·Deborah M Muoio, Christopher B Newgard
Oct 16, 2004·Science·Umut OzcanGökhan S Hotamisligil
Oct 29, 2004·The Journal of Biological Chemistry·Yoshihisa NakataniMunehide Matsuhisa
Apr 11, 2007·Archives of Neurology·José A LuchsingerRichard Mayeux
Apr 12, 2007·Obesity·Roland BuettnerL Cornelius Bollheimer
Jun 15, 2007·Nature Reviews. Molecular Cell Biology·David Ron, Peter Walter
Nov 6, 2007·Antioxidants & Redox Signaling·Jyoti D Malhotra, Randal J Kaufman
Nov 27, 2007·Cellular and Molecular Life Sciences : CMLS·M Schröder
Nov 28, 2007·Annual Review of Pathology·Jonathan H LinT S Benedict Yen
Dec 1, 2007·Endocrine Reviews·Décio L EizirikMiriam Cnop
Dec 28, 2007·American Journal of Physiology. Endocrinology and Metabolism·David J LloydMurielle M Véniant
Feb 16, 2008·Endocrinology·Susan A FarrJohn E Morley
Oct 16, 2008·Current Alzheimer Research·Karen F NeumannRicardo B Maccioni
Jul 14, 2009·Diabetes·Andrea M VincentEva L Feldman
Aug 29, 2009·BMB Reports·Suzanne M de la Monte
Feb 20, 2010·International Journal of Cell Biology·Afshin SamaliSanjeev Gupta
Mar 10, 2010·Disease Models & Mechanisms·Arion J KennedyAlyssa H Hasty
Sep 16, 2010·Nature Reviews. Neurology·Catrina Sims-RobinsonEva L Feldman
Oct 28, 2010·Nature Reviews. Cardiology·Vera Novak, Ihab Hajjar
Nov 13, 2010·Annals of the New York Academy of Sciences·Bengt F Belgardt, Jens C Brüning
Jul 20, 2011·Sangyō eiseigaku zasshi = Journal of occupational health·Hirokazu TakahashiTakemasa Watanabe
Aug 4, 2011·Endocrinology·Bhumsoo KimEva L Feldman
Mar 27, 2012·Annual Review of Biochemistry·Sung Hoon Back, Randal J Kaufman
Oct 13, 2012·Experimental Neurology·Lucy M HinderEva L Feldman
Dec 22, 2012·Epidemiologic Reviews·Anna K Dahl, Linda B Hassing

❮ Previous
Next ❯

Citations

Aug 28, 2019·Neurobiology of Disease·Joy Jones BuieCatrina Sims-Robinson
Jun 11, 2021·Nature Reviews. Endocrinology·Thomas SchererChristoph Buettner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.